|
| 36732161 | Corrigendum to Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH [J Thromb Haemost. 2022 Jul;20(7):1735-1743]. | J Thromb Haemost | 2023 |
| 38057072 | Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease. | J Am Coll Cardiol | 2023 |
| 37461140 | Poly(adenosine diphosphate-ribose) polymerase inhibitor combinations in first-line metastatic castrate-resistant prostate cancer setting: a systematic review and meta-analysis. | BJU Int | 2023 |
| 37063770 | Physical activity for children with deep vein thrombosis and pulmonary embolism on anticoagulation: a scoping review. | Res Pract Thromb Haemost | 2023 |
| 36739234 | Functional impact of pediatric postthrombotic syndrome. | J Thromb Haemost | 2023 |
| 36763520 | Unraveling the pathophysiology of lower-limb postthrombotic syndrome in adolescents: a proof-of-concept study. | Blood Adv | 2023 |
| 34687696 | Direct Oral Anticoagulants: Overcoming the Challenges of Managing Venous Thromboembolism in Children. | J Pediatr | 2022 |
| 35731233 | Defining vascular anomaly phenotypes in children based on a systematic literature search: A critical step in developing a single severity score for interventional clinical trials. | Pediatr Blood Cancer | 2022 |
| 35503347 | Anticoagulant Therapy for 6 Weeks vs 3 Months and Recurrence and Bleeding in Patients Younger Than 21 Years With Provoked Venous Thromboembolism-Reply. | JAMA | 2022 |
| 35570328 | Recommendations for standardized definitions, clinical assessment, and future research in pediatric clinically unsuspected venous thromboembolism: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis. | J Thromb Haemost | 2022 |
| 35570324 | Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH. | J Thromb Haemost | 2022 |
| 35389524 | Characterization of recurrent thrombosis in pediatric antiphospholipid syndrome. | Am J Hematol | 2022 |
| 35748322 | Practical considerations and consensus opinion for children's hospital-based inpatient hemostasis and thrombosis (HAT) consultative services: Communication from the ISTH SSC Subcommittee on Pediatric/Neonatal Thrombosis and Hemostasis. | J Thromb Haemost | 2022 |
| 35686828 | Forward: Welcome to the Special Issue on Vascular Anomalies. | Pediatr Blood Cancer | 2022 |
| 36456034 | Cerebral Sinovenous Thrombosis in Infants and Children: A Practical Approach to Management. | Semin Pediatr Neurol | 2022 |
| 36150047 | Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia. | Blood Adv | 2022 |
| 35909257 | Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials. | Thromb Haemost | 2022 |
| 35919876 | Impact of deep vein thrombosis on adolescent athletes: Navigating an invisible disability. | Res Pract Thromb Haemost | 2022 |
| 36006613 | Anticoagulation in pediatric cancer-associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr. | Blood Adv | 2022 |
| 36344025 | Hemostatic and Thrombotic Considerations in the Diagnosis and Management of Childhood Arterial Ischemic Stroke: A Narrative Review. | Semin Pediatr Neurol | 2022 |
| 34970673 | Pediatric Organ Dysfunction Information Update Mandate (PODIUM) Contemporary Organ Dysfunction Criteria: Executive Summary. | Pediatrics | 2022 |
| 34970670 | Coagulation Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference. | Pediatrics | 2022 |
| 35238712 | Successful Pediatric Mechanical Thrombectomy for HeartMate 3-Related Intracranial Thromboembolism. | World J Pediatr Congenit Heart Surg | 2022 |
| 34587483 | Acute Management of High-Risk and Intermediate-Risk Pulmonary Embolism in Children: A Review. | Chest | 2022 |
| 33290737 | Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial. | Lancet Haematol | 2021 |
| 33651481 | Pediatric May-Thurner Syndrome-Systematic review and individual patient data meta-analysis. | J Thromb Haemost | 2021 |
| 33848369 | Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from CYP-C. | Am J Hematol | 2021 |
| 33706398 | Validation of Outcome Instruments for Pediatric Postthrombotic Syndrome: Introducing the Peds-VEINES-QOL, a New Health-Related Quality of Life Instrument. | Thromb Haemost | 2021 |
| 33616995 | Secondary Anticoagulation Prophylaxis for Catheter-Related Thrombosis in Pediatric Intestinal Failure: Comparison of Short- Vs Long-Term Treatment Protocols. | JPEN J Parenter Enteral Nutr | 2021 |
| 33636042 | Pharmacokinetic modeling and simulation support for age- and weight-adjusted dosing of dabigatran etexilate in children with venous thromboembolism. | J Thromb Haemost | 2021 |
| 33930198 | Diagnostic value of D-dimers for limb deep vein thrombosis in children: A prospective study. | Am J Hematol | 2021 |
| 33689492 | Characterization of physical literacy in children with chronic medical conditions compared with healthy controls: a cross-sectional study. | Appl Physiol Nutr Metab | 2021 |
| 34474480 | Characteristics of upper- and lower-extremity deep vein thrombosis and predictors of postthrombotic syndrome in children. | Blood Adv | 2021 |
| 34418289 | Compression garments for the management of pediatric post-thrombotic syndrome: A prospective longitudinal study. | J Thromb Haemost | 2021 |
| 34152075 | Hemorrhagic transformation and stroke recurrence in children with cardiac disease receiving antithrombotic therapy for secondary stroke prevention. | J Thromb Haemost | 2021 |
| 33971679 | Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Thromboprophylaxis: A Systematic Review of the Literature. | Semin Thromb Hemost | 2021 |
| 31221393 | Abnormal hemostasis in children with vascular anomalies, part I: Thrombocytopenias among different vascular anomalies. | Thromb Res | 2020 |
| 31673144 | CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis. | Pharmacogenomics J | 2020 |
| 31805182 | Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children. | Blood | 2020 |
| 32065663 | Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization. | Cochrane Database Syst Rev | 2020 |
| 33186402 | Risk factors for the development of hospital-acquired pediatric venous thromboembolism-Dealing with potentially causal and confounding risk factors using a directed acyclic graph (DAG) analysis. | PLoS One | 2020 |
| 33069295 | Coagulation issues in vascular anomalies. | Semin Pediatr Surg | 2020 |
| 32817778 | Use of drug-coated balloons in the management of a recalcitrant postsurgical hepatic vein stenosis in a pediatric patient. | Radiol Case Rep | 2020 |
| 32951663 | Cancer and Tumor-Associated Childhood Stroke: Results From the International Pediatric Stroke Study. | Pediatr Neurol | 2020 |
| 32697954 | Bleeding risk associated with combination thromboprophylaxis therapy is low for patients with coronary artery aneurysms after Kawasaki disease. | Int J Cardiol | 2020 |
| 32614496 | Predictors of postthrombotic syndrome in pediatric thrombosis: A systematic review and meta-analysis of the literature. | J Thromb Haemost | 2020 |
| 32640269 | Heparin-Induced Thrombocytopenia in a Pediatric Population: Implications for Clinical Probability Scores and Testing. | J Pediatr | 2020 |
| 32557627 | Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children. | Cochrane Database Syst Rev | 2020 |
| 30528575 | Characterization of Post-Thrombotic Syndrome in Children with Cardiac Disease. | J Pediatr | 2019 |
| 31442694 | Compression stockings to prevent post-thrombotic syndrome in adults, a Bayesian meta-analysis. | Thromb Res | 2019 |